Skip to main content

Alibaba Health Information Technology Limited (0241.HK)

Hong Kong Stock Exchange Healthcare Medical - PharmaceuticalsView data quality →
55.0Fair

ValueMarkers Composite Index

Top 53%#21,014 of 44,707
Overvalued

116% above intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
5/9
Neutral
Beneish
-2.28
Low Risk
Altman
11.71
Safe
DCF Value
$0
Overvalued
ROIC
9.1%
Adequate
P/E
32.9
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Alibaba Health Information Technology Limited (0241.HK) — VMCI valuation read

Alibaba Health Information Technology Limited (0241.HK) carries a VMCI composite of 55/100, 5 points above the Healthcare sector median of 50. Among mid-cap names, that gap places 0241.HK in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The 0241.HK insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads 0241.HK trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 3.4x is the binding constraint on the bear case, the line to track on Alibaba Health Information Technology Limited's next 10-Q.

0241.HK fell 0.9% over the trailing 7 days, with a -10.5% read on a 30-day basis.

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark. In addition, it engages in the tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong.

CEO: Difan Shen1,422 employeesHKwww.alihealth.cn

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 0241.HK’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.